GLP-1 receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 ...

Erectile dysfunction (ED), a common and highly treatable condition, affects millions of men, many starting to have symptoms in middle age. A new drug is being investigated to help those who don’t find ...

This article was reviewed by Mike Bohl, MD, MBA, MPH, MS, ALM. When you’re looking for solutions to improve your intimate function, it’s easy to get overwhelmed by the vast array of treatments ...

FDA regulatory context, and consumer verification steps for men evaluating doctor-prescribed ED medication access online in ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

In an era of remote care and expanding access to men's health treatments, it would seem as if erectile dysfunction (ED) is easier to talk about. But, for many men, ED remains challenging to treat. New ...

H2 2025: Request meeting with FDA to discuss 505(b)(2) pathway. H2 2025: Target submission of New Drug Application (NDA). Sublingual ED medication H1 2026: Finalize formulation and manufacture test ...